Neuropathy's Role in Blood Disorders
Normally, nerve fibres in the bone marrow help create a healthy microenvironment for stem cells, ensuring proper blood cell production. When these fibres are damaged by the mutant blood cells, neuropathy can occur, promoting blood cancer progression. CRESCO Deputy Director Lorena Arranz and other researchers found for the first time that neuropathy contributes to the growth of mutant cancer cells in myeloproliferative neoplasms (MPN), and others followed with its contribution to acute myeloid leukemia (AML). This suggests that repairing damaged nerve fibres could help stop blood cancer progression.
Expanding Research Insights
The team of Dr. Arranz have now discovered that neuropathy is not only present in MPN and AML but it is a prevalent factor in blood cancer models, emerging also in pre-leukemic myeloid conditions and certain lymphomas. In pre-leukemic myeloid leukemia, nerve damage acts as a cooperative event that accelerates disease driven by the primary lesion but not transformation into AML.
Their research also points to severe ultrastructural damage in bone marrow sympathetic fibres of AML patients. Thus, in the future, it will be important to investigate the degree of neural fibre regeneration after curative strategies against hematopoietic malignancies or potential long-term effects that could impair normal HSC function or promote relapse.
Additionally, chemotherapy, a common treatment for blood cancers, induces neuropathy. This means that physicians should consider the impact of nerve damage when planning treatments for patients.
Promising Therapies and Future Steps
Dr. Arranz together with Dr. Mendez-Ferrer and Dr. Isern hold a patent for the use of neuroprotective compounds and β-3 adrenergic receptor agonists, in the treatment of MPNs. For example, a drug called mirabegron has shown potential in restoring nerve cell function and thereby healing other stem cell niche components in MPN patients, offering hope for better outcomes.
Understanding and addressing neuropathy could lead to more effective treatments for a broad variety of blood cancers. By focusing on repairing nerve fibers in the bone marrow, there is potential for improved therapies that will enhance patient recovery and survival.
In summary, this new understanding of neuropathy in bone marrow is paving the way for breakthroughs in treating blood cancers, offering hope for better patient care and quality of life.